Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Enanta Pharmaceuticals Inc. buy JPMorgan Chase & Co.

Enanta Pharmaceuticals Inc.
Start price
€10.60
14.11.25 / 50%
Target price
€14.61
14.11.26
Performance (%)
2.83%
Price
€10.70
27.03.26
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 2.83%. This prediction currently runs until 14.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Enanta Pharmaceuticals Inc. 0.943% 0.943%
iShares Core DAX® -0.479% -12.062%
iShares Nasdaq 100 -3.377% -5.130%
iShares Nikkei 225® -0.143% -12.633%
iShares S&P 500 -2.266% -5.049%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Enanta Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 2.83%
Target price 14.612
Change
Ends at 14.11.26

Enanta Pharmaceuticals (NASDAQ:ENTA) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $17.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat

JPMorgan Chase & Co. 
0
Report Share
14.11.25

Stopped prediction by JPMorgan_Chase___Co_ for Enanta Pharmaceuticals Inc.

sell
Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€11.50
06.08.24
€9.15
06.08.25
-47.83%
07.08.25

JPMorgan Chase & Co. 
06.08.24 50%
sell
Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.70
09.08.23
€12.75
09.08.24
-25.17%
10.08.24

JPMorgan Chase & Co. 
09.08.23 50%